Home > Articles > Search Results: Type 2 diabetes

Articles

  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Articles 81 records found  previous11 - 20nextend  jump to record: Search took 0.02 seconds. 
11.
12 p, 1.2 MB Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes : A Systematic Review and Meta-Analysis / Xie, Suyi (The Chinese University of Hong Kong) ; Li, Qi (The Chinese University of Hong Kong) ; Luk, Andrea O. Y. (The Chinese University of Hong Kong) ; Lan, Hui-Yao (The Chinese University of Hong Kong) ; Chan, Paul K. S. (The Chinese University of Hong Kong) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Chan, Francis K. L. (The Chinese University of Hong Kong) ; Fung, Erik (The Chinese University of Hong Kong) ; Universitat Autònoma de Barcelona. Departament de Medicina
Background: Growth differentiation factor 15 (GDF-15) is a homeostatic cytokine that regulates neural and cardio-metabolic functions, and its release is increased in response to stress, injury, and inflammation. [...]
2022 - 10.3390/biom12070934
Biomolecules, Vol. 12, Num. 7 (july 2022)  
Detailed record - Creative Commons
12.
15 p, 867.3 KB Cardiovascular disease in type 2 diabetes mellitus : progress toward personalized management / Ma, Cheng-Xu (The First Clinical Medical College of Lanzhou University) ; Ma, Xiao-Ni (The First Clinical Medical College of Lanzhou University) ; Guan, Cong-Hui (The First Clinical Medical College of Lanzhou University) ; Li, Ying-Dong (College of Integrated Traditional Chinese and Western Medicine. Gansu University of Chinese Medicine) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Fu, Song-Bo (The First Clinical Medical College of Lanzhou University) ; Universitat Autònoma de Barcelona
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore novel preventive approaches, individualized glycemic control and cardiovascular risk management (strict blood pressure and lipid control), together with recently developed glucose-lowering agents and lipid-lowering drugs. [...]
2022 - 10.1186/s12933-022-01516-6
Cardiovascular diabetology, Vol. 21 Núm. 1 (december 2022) , p. 74  
Detailed record - Creative Commons
13.
9 p, 1.3 MB Longitudinal deep learning clustering of Type 2 Diabetes Mellitus trajectories using routinely collected health records / Manzini, Enrico (Institut de Recerca Sant Joan de Déu) ; Vlacho, Bogdan (DAP-Cat Group. Unitat de Suport a la Recerca. Fundaciò Institut Universitari per a la recerca a l'Atenciò Primària de Salut Jordi Gol i Gurina (IDIAPJGol)) ; Franch-Nadal, Josep (Primary Health Care Center Raval Sud. Institut Català de la Salut) ; Escudero, J. (Grupo Pulso) ; Génova, A. (Grupo Pulso) ; Reixach, Elisenda (Fundació TIC Salut Social. Departament de Salut. Generalitat de Catalunya) ; Andrés, E. (Fundació TIC Salut Social. Departament de Salut. Generalitat de Catalunya) ; Pizarro, I. (Novo Nordisk) ; Portero, J.L. (Novo Nordisk) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Perera Lluna, Alexandre (Institut de Recerca Sant Joan de Déu)
Type 2 diabetes mellitus (T2DM) is a highly heterogeneous chronic disease with different pathophysiological and genetic characteristics affecting its progression, associated complications and response to therapies. [...]
2022 - 10.1016/j.jbi.2022.104218
Journal of Biomedical Informatics, Vol. 135 (november 2022) , p. 104218  
Detailed record - Creative Commons
14.
13 p, 1.3 MB Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older : Data from a Population Database in Catalonia, Spain / Mata-Cases, Manel (Institut Català de la Salut. ABS La Mina (Barcelona)) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Real, Jordi (DAP-Cat Group. Unitat de Suport a la Recerca Barcelona Ciutat. IDIAP Jordi Gol) ; Vlacho, Bogdan (DAP-Cat Group. Unitat de Suport a la Recerca Barcelona Ciutat. IDIAP Jordi Gol) ; Romera-Liebana, Laura (Institut Català de la Salut. Centre d'Atenció Primària Raval Nord (Barcelona, Catalunya)) ; Molist-Brunet, Núria (Universitat de Vic. Grup de Recerca en Cronicitat de la Catalunya Central (C3RG)) ; Cedenilla, Marta (Medical Affairs Department. MSD Spain) ; Franch-Nadal, Josep (Institut Català de la Salut. Centre d'Atenció Primària Raval Sud (Barcelona, Catalunya))
Aim: To assess the potential risk of overtreatment in patients with type 2 diabetes (T2DM) aged 75 years or older in primary care. Methods: Electronic health records retrieved from the SIDIAP database (Catalonia, Spain) in 2016. [...]
2022 - 10.3390/jcm11175134
Journal of clinical medicine, Vol. 11 Núm. 17 (september 2022) , p. 5134  
Detailed record - Creative Commons
15.
6 p, 427.7 KB Retinal sensitivity and gaze fixation evaluated by microperimetry in subjects with type 2 diabetes : two independent parameters that explore different neuronal circuits / Ortiz-Zúñiga, Ángel Michael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rojano-Toimil, Alba (Hospital Universitari Vall d'Hebron) ; Rahnama Zand, Kimia (Hospital Universitari Vall d'Hebron) ; Lainez, Elena (Hospital Universitari Vall d'Hebron) ; Raguer, Nuria (Hospital Universitari Vall d'Hebron) ; Simó-Servat, Olga (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ; Ciudin, Andreea (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Retinal sensitivity (RS) and gaze fixation (GF) assessed by retinal microperimetry are useful and complementary tools for identifying mild cognitive impairment (MCI) in patients with type 2 diabetes (T2D). [...]
2023 - 10.1007/s40618-023-02046-y
Journal of Endocrinological Investigation, Vol. 46 (march 2023) , p. 1875-1880  
Detailed record - Creative Commons
16.
17 p, 601.3 KB Assessing the Feasibility and Acceptability of a Primary Care Socio-Ecological Approach to Improve Physical Activity Adherence among People with Type 2 Diabetes : The SENWI Project / Jabardo-Camprubí, Guillem (Universitat de Vic. Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central) ; Puig-Ribera, Anna (Universitat de Vic. Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central) ; Donat-Roca, Rafel (University of Vic-Central University of Catalonia. Faculty of Health Science at Manresa) ; Farrés-Godayol, Pau (University of Vic-Central University of Catalonia. Faculty of Health Sciences and Welfare) ; Nazar-Gonzalez, Sebastian (Ramon Llull University. Department of Physical Therapy) ; Sitjà-Rabert, Mercè (Ramon Llull University. Faculty of Health Science Blanquerna) ; Espelt, Albert 1981- (Universitat Autònoma de Barcelona. Departament de Psicobiologia i de Metodologia de Ciències de la Salut) ; Bort-Roig, Judit (Universitat de Vic. Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central)
Maintaining an active lifestyle is a key health behavior in people with type 2 diabetes (T2D). This study assessed the feasibility and acceptability of a socio-ecological Nordic walking intervention (SENWI) to enhance healthy behaviors in primary healthcare settings. [...]
2023 - 10.3390/healthcare11131815
Healthcare, Vol. 11 (june 2023) , article number 1815  
Detailed record - Creative Commons
17.
10 p, 1.7 MB Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes : Barriers and solutions for improving uptake in routine clinical practice / Khunti, Kamlesh (NIHR Applied Research Collaboration - East Midlands) ; Jabbour, Serge (Thomas Jefferson University) ; Cos Claramunt, Francesc Xavier (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Mudaliar, Sunder (Veterans Affairs Medical Center) ; Mende, Christian (University of California San Diego) ; Bonaca, Marc (University of Colorado School of Medicine) ; Fioretto, Paola (University of Padua) ; Universitat Autònoma de Barcelona
Recent advances in type 2 diabetes (T2D) research have highlighted the benefits of sodium-glucose co-transporter-2 (SGLT-2) inhibitors, including cardiovascular and renal protection. However, uptake rates of these drugs remain low in patients with T2D, particularly in subpopulations most likely to benefit from them. [...]
2022 - 10.1111/dom.14684
Diabetes, Obesity and Metabolism, Vol. 24 (march 2022) , p. 1187-1196  
Detailed record - Creative Commons
18.
7 p, 700.1 KB New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes / Ciudin, Andreea (Hospital Universitari Vall d'Hebron) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The presence of type 2 diabetes acts as an accelerator of cognitive impairment (mild cognitive impairment and later dementia), with a significant impact on the management of the disease and its complications. [...]
2022 - 10.3389/fendo.2022.1024794
Frontiers in Endocrinology, Vol. 13 (december 2022)  
Detailed record - Creative Commons
19.
12 p, 1.2 MB Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus : Findings from Clinical and Experimental Studies / Alcubierre, Nuria (Avantmèdic (LLeida)) ; Granado-Casas, Minerva (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Bogdanov, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramos, Hugo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Castelblanco, Esmeralda (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Real, Jordi (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Rubinat, Esther (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Traveset, Alicia (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Hernández, Marta (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Jurjo, Carmen (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Vioque, Jesús (Instituto de Salud Carlos III) ; Navarrete-Muñoz, Eva Maria (Instituto de Investigación Sanitaria y Biomédica de Alicante) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of diabetic retinopathy (DR) in subjects with type 2 diabetes (T2D). Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. [...]
2023 - 10.3390/nu15051169
Nutrients, Vol. 15 (february 2023)  
Detailed record - Creative Commons
20.
4 p, 983.4 KB Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly" Resumen ejecutivo sobre el tratamiento de la diabetes mellitus tipo 2 en personas de edad avanzada o frágiles. Actualización 2022 del documento de consenso 2018 «Tratamiento de la diabetes mellitus tipo 2 en el paciente anciano» / Gómez-Peralta, Fernando (Hospital General de Segovia. Unidad de Endocrinología y Nutrición) ; Carrasco-Sánchez, Francisco Javier (Hospital General Juan Ramón Jiménez. Servicio de Medicina Interna) ; Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Escalada, J. (Clínica Universitaria de Navarra. Departamento de Endocrinología y Nutrición) ; Álvarez-Guisasola, F. (Centro de Salud Ribera del Órbigo. León. Grupo de Trabajo de Diabetes. Sociedad Española de Medicina de Familia y Comunitaria (semFYC)) ; Miranda-Fernández-Santos, C. (Centro de Salud Buenavista Toledo. Toledo. Área Cardiovascular y Diabetes de la Sociedad Española de Médicos Generales y de Familia (SEMG)) ; Mediavilla-Bravo, J.J. (Centro de Salud Burgos Rural. Burgos. Sociedad Española de Médicos de Atención Primaria (SEMERGEN)) ; Gómez-Huelgas, R. (Instituto de Investigación Biomédica de Málaga) ; Universitat Autònoma de Barcelona
The population with type 2 DM (DM2) is highly heterogeneous, representing an important challenge for healthcare professionals. The therapeutic choice should be individualized, considering the functional status, frailty, the occurrence of comorbidities, and the preferences of patients and their caregivers. [...]
2022 - 10.1016/j.rce.2022.03.004
Revista Clinica Espanola, Vol. 222 Núm. 8 (octubre 2022) , p. 496-499  
Detailed record - Creative Commons

Articles : 81 records found   previous11 - 20nextend  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with